Please assess the completion status of the following clinical trial:

Trial Title: Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Laparoscopic Gastro-intestinal surgery~Exclusion Criteria:~* Bariatric surgery, gastric surgery, rectal surgery, kidney failure, aorta-valve stenosis, coagulation disorders, emergency surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Spinal injection (Type: ACTIVE_COMPARATOR): Patients receive spinal injection Bupivacaine/Morphine
- Subcutaneum injection (Type: PLACEBO_COMPARATOR): Placebo subcutaneum injections

Based on this trial design, predict the completion outcome and termination type (if applicable).